Abstract:INTRODUCTION:Components of the metabolic syndrome are highly prevalent in chronic kidney disease (CKD) patients--some of which paradoxically appear to predict an improved outcome in this population. We hypothesized that the circulating calcification inhibitor fetuin-A/AHSG, which is also a natural inhibitor of the tyrosine kinase insulin receptor, could be one factor explaining the association between increased fat mass and a survival advantage in CKD and thus conducted an explorational study to provide preliminary data to support further research into this hypothesis. PATIENTS AND METHODS:In a cross-sectional study, we evaluated 198 CKD stage 5 patients (GFR 6.8 +/- 0.2 ml/min; 62% males, mean age 52 +/- 1 years) close to the start of renal replacement therapy. We studied circulating AHSG (ELISA) and two common functional AHSG gene polymorphisms (at amino acids Thr248Met (C-T) and Thr256Ser (C-G) using Pyrosequencing) and related these to multiple components of the metabolic syndrome. RESULTS:Median circulating AHSG was lower (p < 0.01) in type-2 (0.22 g/l) and type-1 (0.16 g/l) diabetics as compared to non-diabetic CKD-5 patients (0.24 g/l). AHSG correlated with both total and truncal fat mass in type-2 diabetics (rho 0.37 and 0.39; p < 0.001, respectively), but not in type-1 diabetics or non-diabetics. Both SNPs significantly influenced circulating levels of AHSG, and were also associated with significant differences in serum triglycerides and HDL cholesterol. Furthermore, there were significant differences in the prevalence of metabolic syndrome criteria between the AHSG Thr256Ser (C-G) genotype groups, with a more atherogenic lipid profile in AHSG high producers (Thr/Thr homozygotes). In multivariate analysis, the association between circulating AHSG and fat mass remained significant also after adjustment for age, gender, inflammation (CRP >10 mg/l), and AHSG genotype. CONCLUSIONS:The present, explorational, study supports further, mechanistic, studies into a physiological link between AHSG and body fat mass in patients with CKD. As we observed an association between higher fat mass and elevated AHSG levels, these preliminary results may form the basis of further study to establish if the observed associations may be one reason why obesity has been reported to constitute a survival advantage in CKD.

Alpha 2‐heremans‐schmid Glycoprotein Gene Polymorphism (rs4918) is Associated with Coronary Artery Calcification in Incident Peritoneal Dialysis Patients

Association Between Polymorphisms of Inflammatory Factor Genes and Coronary Heart Disease

Association of AHSG gene polymorphisms and aortic stiffness in peritoneal dialysis patients

The Association of Ghrelin Polymorphisms with Coronary Artery Disease and Ischemic Chronic Heart Failure in an Elderly Chinese Population

Association Between Peroxisome Proliferator-Activated Receptor-Alpha, Delta, and Gamma Polymorphisms and Risk of Coronary Heart Disease A Case-Control Study and Meta-Analysis

Is Fetuin-A/Alpha 2-Heremans-schmid Glycoprotein Associated with the Metabolic Syndrome in Patients with Chronic Kidney Disease?

Correlation between circulating dephosphorylated uncarboxylated matrix Gla protein and vascular calcification in peritoneal dialysis patients

Association of Matrix Gla Protein Gene (rs1800801, Rs1800802, Rs4236) Polymorphism with Vascular Calcification and Atherosclerotic Disease: a Meta-Analysis.

SAA1 Gene Polymorphisms in Osteoporosis Patients

Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis

ALDH2 Rs671 Polymorphism and the Risk of Heart Failure with Preserved Ejection Fraction (hfpef) in Patients with Cardiovascular Diseases

Correlations of PCSK9 and LDLR Gene Polymorphisms and Serum PCSK9 Levels With Atherosclerosis and Lipid Metabolism in Patients on Maintenance Hemodialysis

Serum Uric Acid Levels Are Associated With Polymorphism In The Saa1 Gene In Chinese Subjects

Polymorphism in the human matrix Gla protein gene is associated with the progression of vascular calcification in maintenance hemodialysis patients

The Association Between Peroxisome Proliferator-Activated Receptor Delta Rs3777744, Rs3798343, And Rs6922548 And Coronary Artery Disease

Lower Serum Irisin Levels Are Associated with Increased Abdominal Aortic Calcification in Peritoneal Dialysis Patients

Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary disease

The significance of serum SLC7A11 levels in the occurrence of vascular calcification in maintenance peritoneal dialysis patients

Genetic Variation Of The Human Alpha-2-Heremans-Schmid Glycoprotein (Ahsg) Gene Associated With The Risk Of Sars-Cov Infection

An Intron Polymorphism in the CXCL16 Gene is Associated with Increased Risk of Coronary Artery Disease in Chinese Han Population: a Large Angiography-Based Study.

Pericardial fat is associated with coronary artery calcification in non-dialysis dependent chronic kidney disease patients